Launch week offerEnds in00h00m00s

annual Promonthly Pro

Roberto Alvarez-Lafuente

Has grant

Investigador Principal del Grupo de Investigación de Factores Ambientales en Enfermedades Degenerativas

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos

Spain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Recent Grants

Grant: Close

ÁCIDOS GRASOS DE CADENA CORTA Y ANTICUERPOS FRENTE A pHERV-W ENV Y SINCITINA-1 EN PACIENTES CON DIABETES TIPO 1

Open Date: 2024-09-01

Close Date: 2026-03-01

Grant: Close

ÁCIDOS GRASOS DE CADENA CORTA Y ESCLEROSIS MÚLTIPLE PRIMARIA PROGRESIVA: ESTUDIO DE SU ASOCIACIÓN CON LA PROGRESIÓN DE LA ENFERMEDAD

Open Date: 2024-09-01

Close Date: 2025-09-01

Grant: Close

Metabolitos de la microbiota intestinal como posibles biomarcadores de la Enfermedad de Parkinson

Open Date: 2023-10-01

Close Date: 2026-09-01

Grant: Close

Ultrasensitive detection of anti-HHV-6 major capsid protein IgG in multiple sclerosis patients

Open Date: 2023-07-01

Close Date: 2025-12-01

Grant: Close

Red Española de Esclerosis Múltiple

Open Date: 2023-06-01

Close Date: 2025-05-01

Articles (19)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (20)

Sunny Malhotra Sareen

Principal Investigator

Vall d'Hebron Institut de Recerca

SPAIN

View details

Nicolás Miguel Fissolo

Principal Researcher

Vall d'Hebron Institut de Recerca

SPAIN

View details

Harald Hegen

Senior scientist and consultant neurologist

Medical University of Innsbruck

AUSTRIA

View details

Luisa María Villar

Head of Department

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

SPAIN

View details

Angel Torrado-Carvajal

Assistant Professor

Universidad Rey Juan Carlos

SPAIN

View details

Enric Monreal

Healthcare professional

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

SPAIN

View details

Robert Hoepner

Head of Neuroimmunological Outpatient Department and Neuroimmunological Study Cetner

University Hospital of Bern

SWITZERLAND

View details

Ana Quiroga-Varela

Institut d'Investigació Biomèdica de Girona Dr Josep Trueta

SPAIN

View details

Francisco Pérez-Miralles

Associate Lecturer in Anatomy, Physiology and Neurology of voice, speech and language

University of Valencia

SPAIN

View details

Jan Lunemann

Chair in MS and Autoimmune Neurology Reserach; Director, MS and NMO Program

The University of British Columbia

CANADA

View details

Manuel Comabella

Head of Laboratory

Vall d'Hebron Institut de Recerca

SPAIN

View details

Davide Cossu

Assistant professor

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

ITALY

View details

Luis Brieva Ruiz

Head of the department

Hospital Universitari Arnau de Vilanova

SPAIN

View details

Ioannis Vardakas

Universität Ulm

GERMANY

View details

Konrad Rejdak

Medical University of Lublin

POLAND

View details

Patrick Roth

Professor

University Hospital of Zurich

SWITZERLAND

View details

Rosa del Campo

Profesor a tiempo parcial

Universidad Antonio de Nebrija

SPAIN

View details

Roberto Furlan

Vita-Salute San Raffaele University

ITALY

View details

Claudio Gobbi

Adjunct Professor

Università del Salento

SWITZERLAND

View details

Jose L. Luque-Garcia

Associate Professor

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Roberto Alvarez-Lafuente

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (19)

Bacterial Metabolites in the Plasma of Type 1 Diabetes Patients: Acetate Levels Are Elevated and Correlate with Glycated Haemoglobin and Para-Cresol Is Associated with Liver Disturbances and Hypertension

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis

Differential distribution of antiviral serology across multiple sclerosis phenotypes and its implications for disease pathogenesis

HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosis

Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis

Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis

Short‐chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile

Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis.

Immune response profiling of HERV-W envelope proteins in multiple sclerosis: potential biomarkers for disease progression.

New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis

Editorial: Neuroanatomical and molecular biomarkers for multiple sclerosis progression and therapeutic response.

Serum biomarkers at disease onset for personalized therapy in multiple sclerosis

Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis

Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis

A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression.

Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.

Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.

MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate

Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort: <i>in vivo</i> antiviral activity and clinical response.

Collaborators (20)

Sunny Malhotra Sareen

Nicolás Miguel Fissolo

Harald Hegen

Luisa María Villar

Angel Torrado-Carvajal

Enric Monreal

Robert Hoepner

Ana Quiroga-Varela

Francisco Pérez-Miralles

Jan Lunemann

Manuel Comabella

Davide Cossu

Luis Brieva Ruiz

Ioannis Vardakas

Konrad Rejdak

Patrick Roth

Rosa del Campo

Roberto Furlan

Claudio Gobbi

Jose L. Luque-Garcia

Make your next move.